Warp Speed For All And A Boost For Small Biotechs In Trump’s Second Term, Ex-Official Says

 
• By Sarah Karlin-Smith
Training moving fast.
The FDA may aim to speed up agency reviews during Trump's second term. (Shutterstock)

More from Elections

More from Legislation